Introduction: Harmonizing data across cohorts is important for validating findings or combining data in meta-analyses. We replicate and validate a previous conversion of MoCA to MMSE in PD.
Methods: We used five studies with 1,161 PD individuals and 2,091 observations measured with both the MoCA and MMSE. We compared a previously published conversion table using equipercentile equating with log-linear smoothing to our internally derived scores.
Results: Both conversions found good agreement within and across the studies when comparing true and converted MMSE (mean difference: 0.05; standard deviation: 1.84; median difference: 0; interquartile range: -1 to 1, using internal conversion).
Conclusions: These results show that one can get a reliable and valid conversion between two commonly used measures of cognition in PD studies. These approaches need to be applied to other scales and domains to enable large-scale collaborative analyses across multiple PD cohorts.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864892 | PMC |
http://dx.doi.org/10.1002/mds.26498 | DOI Listing |
Ann Neurosci
January 2025
Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, Delhi, India.
Background: Studies suggest that obesity predisposes individuals to developing cognitive dysfunction and an increased risk of dementia, but the nature of the relationship remains largely unexplored for better prognostic predictors.
Purpose: This study, the first of its kind in Indian participants with obesity, was intended to explore the use of quantification of different neurocognitive indices with increasing body mass index (BMI) among middle-aged participants with obesity. Additionally, machine-learning models were used to analyse the predictive performance of BMI for different cognitive functions.
Appl Neuropsychol Adult
January 2025
Department of Rehabilitation Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, China.
Objective: This study evaluated the reliability and validity of the In-Out-Test for detecting episodic memory deficits in stroke patients and explored its potential as a clinical test.
Methods: A total of 75 stroke patients and 120 healthy controls underwent tests, including the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Picture-Based Memory Impairment Screen (PMIS), and In-Out-Test. Reliability metrics (Cronbach's α, inter-scorer reliability, test-retest reliability), criterion validity, corrected item-total correlation, hierarchical regression analysis and ROC curve analysis were performed to determine the sensitivity and specificity of the In-Out-Test.
Gen Hosp Psychiatry
January 2025
Nursing College, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, China.
Background And Purpose: Cognitive function is the basis of human thinking and behavior. Cognitive impairment has a serious impact on each individual and imposes a financial burden to families and healthcare systems. Inhalation aromatherapy has advantages, due to its safety, convenience, lack of toxicity, and wide use in the treatment of cognitive impairment.
View Article and Find Full Text PDFJ Med Life
November 2024
Department of Medical Physics and Biophysics, Medical University-Pleven, Pleven, Bulgaria.
With advances in scientific and clinical knowledge, stroke has evolved from a major cause of death to a chronic condition affecting the daily lives of sufferers, their relatives, and society. Post-stroke cognitive impairment (PSCI) is common even among individuals with good neurological recovery. When deciding on interventions aimed to improve the life quality of post-stroke patients, identifying those at high risk of cognitive decline proves crucial.
View Article and Find Full Text PDFRep Pract Oncol Radiother
December 2024
Department of Radiotherapy, Chair of Oncology, Medical University, Lodz, Poland.
Background: In small cell lung cancer (SCLC), limiting the radiation dose in the hippocampus area during preventive cranial irradiation (PCI) can reduce nerve injury and cognitive decline. This study was done to compare changes in cognitive functions between hippocampal-protected (3D-H) and non-hippocampal-protected (3D) patients during PCI.
Materials And Methods: the study group included 113 patients with SCLC qualified to PCI divided in two subgroups: 3D-H (n = 74) and 3D (n = 39).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!